Sharp Mary Birch Hospital for Women & Newborns, part of Sharp HealthCare, is a 206-bed, not for profit hospital. Located in San Diego, California, Sharp Mary Birch Hospital delivers more babies than any other hospital in California.

There are 206 beds in Sharp Mary Birch Hospital for Women and Newborns.

During the past decade, Sharp Mary Birch Hospital for Women and Newborns conducted 36 clinical trials. In the 10-year time frame, 36 clinical trials started and 9 clinical trials were completed, i.e. on average, 25% percent of trials that started reached the finish line to date. In the past 5 years, 19 clinical trials started and 3 clinical trials were completed. i.e. 15.8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Sharp Mary Birch Hospital for Women and Newborns" #1 sponsor was "Sharp HealthCare" with 23 trials, followed by "Windtree Therapeutics" with 3 trials sponsored, "Mallinckrodt" with 2 trials sponsored, "ONY" with 2 trials sponsored and "University of Pennsylvania" with 2 trials sponsored. Other sponsors include 10 different institutions and companies that sponsored additional 20 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Sharp Mary Birch Hospital for Women and Newborns" #1 collaborator was "Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)" with 9 trials as a collaborator, "Sharp Mary Birch Hospital for Women & Newborns" with 9 trials as a collaborator, "University of Alberta" with 5 trials as a collaborator, "Loma Linda University" with 4 trials as a collaborator and "Providence Hospital" with 3 trials as a collaborator. Other collaborators include 57 different institutions and companies that were collaborators in the rest 44 trials.

According to Clinical.Site data, the most researched conditions in "Sharp Mary Birch Hospital for Women and Newborns" are "Respiratory Distress Syndrome" (5 trials), "Extreme Prematurity" (4 trials), "Birth Asphyxia" (2 trials), "Bronchopulmonary Dysplasia" (2 trials) and "Death; Neonatal" (2 trials). Many other conditions were trialed in "Sharp Mary Birch Hospital for Women and Newborns" in a lesser frequency.

Most popular intervention types in "Sharp Mary Birch Hospital for Women and Newborns" are "Procedure" (15 trials), "Drug" (14 trials), "Device" (9 trials), "Other" (7 trials) and "Combination Product" (2 trials). Other intervention types were less common.

The name of intervention was led by "Umbilical Cord Milking" (5 trials), "Early Cord Clamping" (4 trials), "Delayed Cord Clamping" (2 trials), "Ibuprofen" (2 trials) and "Placebo" (2 trials). Other intervention names were less common.

The vast majority of trials in "Sharp Mary Birch Hospital for Women and Newborns" are 42 trials for "All" genders and 5 trials for "Female" genders.

Currently, there are NaN active trials in "Sharp Mary Birch Hospital for Women and Newborns". undefined are not yet recruiting, 8 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 27 completed trials in Sharp Mary Birch Hospital for Women and Newborns, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Sharp Mary Birch Hospital for Women and Newborns, 2 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 20 trials that are defined as “Not Applicable".